-+ 0.00%
-+ 0.00%
-+ 0.00%

NEUROCRINE BIOSCIENCES - INGREZZA Q3 2026 NET PRODUCT SALES $801 MLN, UP 17% YEAR-OVER-YEAR - SEC FILING

Reuters·11/02/2026 21:34:14

Please log in to view news